Fidelity Investments
SONM icon

Fidelity Investments’s DNA X Inc SONM Stock Holding History

Fidelity Investments’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$442 – 5568
2025
Q2 		$442 Buy
+20
New +$493 ﹤0.01% 5044
2024
Q3 		– Hold
0
– -$20 – 5710
2024
Q2 		– Sell
-1
Closed -$109 – 5206
2024
Q1 		$83 Buy
+1
New +$123 ﹤0.01% 4989
2023
Q1 		– Sell
-1
Closed -$40 – 5505
2022
Q4 		$40 Sell
1
-55
-98% -$4.52K ﹤0.01% 4984
2022
Q3 		$5K Buy
56
+54
+2,700% +$6.71K ﹤0.01% 4334
2022
Q2 		$0 Buy
2
+1
+100% +$113 ﹤0.01% 5437
2022
Q1 		$0 Buy
+1
New +$135 ﹤0.01% 5434

Other funds holding SONM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return

Fidelity Investments's SONM Position: Q3 2025 in Review

Fidelity Investments sold out of DNA X Inc (SONM) in Q3 2025, closing a stake of 20 shares — an estimated $442 sold.

Fidelity Investments first reported a position in SONM in Q1 2022 and held it in 6 quarters. The position peaked at $5K in Q3 2022. 12 funds tracked by Wall St. Rank hold SONM as of Q3 2025.

  • Fidelity Investments reported no remaining DNA X Inc position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 20 DNA X Inc shares in Q3 2025, an estimated $442.
  • Fidelity Investments first reported a position in DNA X Inc in Q1 2022 and held it in 6 quarters.
  • Fidelity Investments's DNA X Inc position peaked at $5K in Q3 2022.
  • 12 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.